9 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
The discovery of potent selective NPY Y(2) antagonists.
Janssen Research and Development
Discovery of microsomal triglyceride transfer protein (MTP) inhibitors with potential for decreased active metabolite load compared to dirlotapide.
Pfizer
Identification and structure-activity relationships of ortho-biphenyl carboxamides as potent Smoothened antagonists inhibiting the Hedgehog signaling pathway.
Novartis Institutes For Biomedical Research
In vitro and in vivo profile of 5-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-1H-indole-2-carboxylic acid benzylmethyl carbamoylamide (dirlotapide), a novel potent MTP inhibitor for obesity.
Pfizer
Discovery of potent and orally active MTP inhibitors as potential anti-obesity agents.
Pfizer
5-Carboxamido-1,3,2-dioxaphosphorinanes, potent inhibitors of MTP.
Bristol-Myers Squibb Pharmaceutical Research Institute
Microsomal triglyceride transfer protein inhibitors: discovery and synthesis of alkyl phosphonates as potent MTP inhibitors and cholesterol lowering agents.
Bristol-Myers Squibb Pharmaceutical Research Institute
Diaminoindanes as microsomal triglyceride transfer protein inhibitors.
Novartis Institute For Biomedical Reasearch